Paper3024322
Proteolytic enzymes in cancer invasion and metastasis.
Goldfarb RH and 1 other. Semin Thromb Hemost, 1986. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Proteolytic enzymes in cancer invasion and metastasis. Papers, record 3024322. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3024322
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Invasiveness | Major topic |
| Neoplasm Metastasis | Major topic |
| Peptide Hydrolases | Major topic |
| Cathepsin B | |
| Endopeptidases | |
| Extracellular Matrix | |
| Fibrinolysin | |
| Glycoside Hydrolases | |
| Humans | |
| Microbial Collagenase | |
| Plasminogen Activators | |
| Serine Endopeptidases |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38557916 | Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38557916 | PubMed |
| 37057291 | The most likely but largely ignored triggering factor for breast (or all) cancer invasion. | J Cancer | 2023 | https://conductscience.org/library/papers/37057291 | PubMed |
| 32216826 | Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. | Breast Cancer Res | 2020 | https://conductscience.org/library/papers/32216826 | PubMed |
| 28249898 | Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution. | Cancer Res | 2017 | https://conductscience.org/library/papers/28249898 | PubMed |
| 27648124 | Invasive ductal carcinoma with in situ pattern: how to avoid this diagnostic pitfall? | Am J Transl Res | 2016 | https://conductscience.org/library/papers/27648124 | PubMed |
| 25057306 | Metastatic hepatocarcinoma he/de tumor model in rat. | J Cancer | 2014 | https://conductscience.org/library/papers/25057306 | PubMed |
| 23532368 | Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression? | Int J Med Sci | 2013 | https://conductscience.org/library/papers/23532368 | PubMed |
| 23386907 | Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. | J Cancer | 2013 | https://conductscience.org/library/papers/23386907 | PubMed |
| 23355797 | Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis? | Int J Biol Sci | 2013 | https://conductscience.org/library/papers/23355797 | PubMed |
| 21811519 | Malignant transformation and stromal invasion from normal or hyperplastic tissues: true or false? | J Cancer | 2011 | https://conductscience.org/library/papers/21811519 | PubMed |
| 20842227 | Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues. | J Cancer | 2010 | https://conductscience.org/library/papers/20842227 | PubMed |
| 20842226 | A seemingly most effective target for early detection and intervention of prostate tumor invasion. | J Cancer | 2010 | https://conductscience.org/library/papers/20842226 | PubMed |
| 20842222 | Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion? | J Cancer | 2010 | https://conductscience.org/library/papers/20842222 | PubMed |
| 20224734 | Aberrant leukocyte infiltration: a direct trigger for breast tumor invasion and metastasis. | Int J Biol Sci | 2010 | https://conductscience.org/library/papers/20224734 | PubMed |
| 20036817 | Role of myoepithelial cells in breast tumor progression. | Front Biosci (Landmark Ed) | 2010 | https://conductscience.org/library/papers/20036817 | PubMed |
| 19343113 | Correlated alterations in prostate basal cell layer and basement membrane. | Int J Biol Sci | 2009 | https://conductscience.org/library/papers/19343113 | PubMed |
| 18726004 | Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones? | Int J Biol Sci | 2008 | https://conductscience.org/library/papers/18726004 | PubMed |
| 18725981 | Bad seeds produce bad crops: a single stage-process of prostate tumor invasion. | Int J Biol Sci | 2008 | https://conductscience.org/library/papers/18725981 | PubMed |
| 14580259 | Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. | Breast Cancer Res | 2003 | https://conductscience.org/library/papers/14580259 | PubMed |
| 12927046 | A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. | Breast Cancer Res | 2003 | https://conductscience.org/library/papers/12927046 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3024322
GET https://conductscience.org/api/papers/v1/3024322/cited_by?page=2